Managing ADHD in Adults

Diagnostic Confirmation

The American Academy of Pediatrics recommends documenting symptoms present before age 12 years through reliable patient report or collateral information from family members, and verifying current impairment in multiple settings using DSM-5 criteria, to confirm the diagnosis of ADHD in adults 1, 2, 3, 4

The American Academy of Pediatrics suggests screening aggressively for comorbid conditions, including substance use disorders, depression and anxiety disorders, learning disabilities, and sleep disorders, before starting treatment for ADHD in adults 5, 3, 4
Screening for substance use disorders is critical, as untreated ADHD increases the risk for substance abuse, and active substance use must be stabilized before initiating stimulants 5, 3

The American Academy of Pediatrics recommends stimulant medications, such as methylphenidate or amphetamine formulations, as the established first-line treatment for adults with ADHD, which work by inhibiting dopamine and norepinephrine transporters, enhancing prefrontal cortex efficiency and optimizing executive function 1, 2
Long-acting formulations are preferred over short-acting preparations because they provide better medication adherence, lower risk of rebound effects, and reduced potential for diversion or abuse 1, 2

When comorbidities are present, the American Academy of Pediatrics suggests sequencing treatments strategically, prioritizing the treatment of substance use disorder before initiating stimulants, stabilizing mood symptoms that may require immediate attention before addressing ADHD, and considering combined treatment or sequencing based on which condition causes the greatest impairment 5, 3

The American Academy of Pediatrics recommends combining medication with psychosocial interventions, including psychoeducation, behavioral interventions, and involving partner, family, or close relationships in treatment planning and ongoing management, for optimal outcomes in adults with ADHD 1, 2

The American Academy of Pediatrics suggests managing ADHD as a chronic condition requiring long-term follow-up, applying chronic care model principles with regular monitoring and continuous coordinated care, and recognizing that ADHD treatments are frequently not maintained over time, leading to persistent impairments into adulthood 5, 4, 3
Untreated or undertreated ADHD carries serious risks, including increased mortality, suicide, psychiatric comorbidity, lower educational achievement, motor vehicle crashes, criminality, and incarceration 5, 4

The American Academy of Pediatrics warns against missing comorbid substance use disorders, which fundamentally change the treatment approach and require stabilization first, and against treating ADHD as an acute condition, which requires ongoing management like any chronic disease 4, 3, 5

The American Academy of Pediatrics recommends explaining ADHD as a chronic, lifelong condition that requires ongoing management rather than a temporary problem that resolves with age, as most patients report not being informed of this critical fact during diagnosis 6, 7
The American Academy of Child and Adolescent Psychiatry suggests presenting comprehensive psychoeducation to all ADHD patients and their families that explains ADHD as a lifelong neurodevelopmental condition, covers treatment options including both medications and behavioral interventions, uses non-stigmatizing language, and includes practical skill-building strategies for managing symptoms in daily life 6, 8

The Australian ADHD Professionals Association recommends adopting language that fosters understanding and hope rather than emphasizing deficits, using resources like their "Talking About ADHD" language guide to avoid judgmental terminology that creates self-stigma and internalized shame 8
The American Academy of Child and Adolescent Psychiatry suggests framing ADHD through a recovery lens that considers the patient's values, feelings, goals, and strengths rather than focusing exclusively on symptom reduction 8, 9
The American Academy of Pediatrics recommends allocating sufficient consultation time to thoroughly explain ADHD and treatment options, as patients consistently report that healthcare professionals lack the time needed to answer questions adequately 6, 7

The American Academy of Pediatrics recommends explaining that FDA-approved medications should be prescribed along with parent training and behavioral classroom interventions for children with ADHD, emphasizing that educational interventions and individualized instructional supports are necessary components 10
The American Academy of Child and Adolescent Psychiatry suggests educating school staff about ADHD, as there is a consistent need for greater understanding among teachers and appropriate guidelines for educators 6, 7, 11

The American Academy of Child and Adolescent Psychiatry recommends avoiding overemphasizing challenges without discussing strengths, goals, and recovery-focused principles that foster hope and quality of life 8, 9
The American Academy of Child and Adolescent Psychiatry suggests not providing education in isolation from broader community awareness efforts, as public education is needed to reduce discrimination and stigma 6, 7, 11